Ventas, Inc. (VTR) Bundle
Jefferies Sets $93 Price Target for Ventas Inc. (NYSE:VTR)
Jefferies established a $93 USD price target for Ventas, Inc. (NYSE:VTR) on December 15, 2025. This valuation indicates a potential upside of approximately 18.2% from the current share price of $78.7.
The healthcare real estate investment trust maintains a solid balance sheet and improved leverage metrics. The company current financial standing and liquidity position are detailed in the VTR-financial-health report.
- The Zacks Consensus Estimate for 2025 funds from operations (FFO) per share has increased to $2.48 USD.
- Ventas shares have appreciated 11.9% over the past three months, while the broader industry saw a 1.5% decline.
- The company maintains a market capitalization of approximately $34.8B with a trading volume of 2,630,940 shares.
Growth is currently driven by senior housing performance and accretive investments in the research portfolio. Ventas competes in the healthcare sector against Welltower and Healthpeak Properties. Further details on corporate strategy are available at VTR-mission-vision and VTR-history-mission-ownership.
The expansion of operations, maintenance, and repair (OM&R) activities continues to support same-store cash net operating income growth. Recent market activity showed the stock trading between $78.22 USD and $79.50. Additional investor data is provided at VTR-investor-profile.
Ventas, Inc. (VTR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.